BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cord Blood Registry Announces Settlement Of Litigation With Viacord


10/28/2005 12:31:22 PM

SAN BRUNO, Calif., Oct. 27 /PRNewswire/ -- Cord Blood Registry ("Cbr") announced today that it has entered into a settlement agreement with Viacord, a division of Viacell, Inc. regarding litigation involving marketing and advertising claims. Under the terms of the settlement agreement, no financial payment will be made by either company, and both companies will dismiss all outstanding claims. No additional terms of the settlement were disclosed.

"We are pleased with the outcome of this settlement," said Tom Moore, CEO of Cbr.

About CBR

Cbr is the world's largest newborn stem cell bank. Cbr's laboratory has been collecting and processing newborn stem cells for family banking since 1992. The company has recorded profits and positive cash flow from its operating activities since 1999, with 106% growth in units banked for the first nine months of 2005 as compared with the first nine months of 2004. Over 350,000 units of cord blood for more than 105,000 newborns are preserved at Cbr's new 80,000-square-foot stem cell facility in Tucson, Arizona. The company's research and development is focused on advancing the collection, processing, and storage methods to deliver the highest quality sample and cell yield. Additionally, Cbr provides donated research samples which are made available for the nearly 200 research programs worldwide that are focused on cord blood stem cell expansion and cell-based therapies. For more information, visit http://www.cordblood.com, or call 1-888-CORD BLOOD.

Cord Blood Registry is a registered trademark of Cbr Systems, Inc. Contact: Rita Kennen Media Relations Manager 650-635-1420 ext. 239 rkennen@cordblood.com

Cord Blood Registry

CONTACT: Rita Kennen, Media Relations Manager of Cord Blood Registry,+1-650-635-1420, ext. 239, or rkennen@cordblood.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES